Key result
Balloon mitral valvotomy was successfully performed in 72 of 74 patients with rheumatic heart disease, with a complication rate of 2.7% and no mortality.
Why the study?
Rheumatic heart disease remains a leading cause of valvular heart disease in India, prompting evaluation of RHD patient outcomes and the safety and efficacy of BMV in a tertiary care center.
Is balloon mitral valvotomy safe and effective for patients with rheumatic heart disease in a tertiary care setting?
Observational (n=500)
No
Is balloon mitral valvotomy safe and effective for patients with rheumatic heart disease in a tertiary care setting?
Percutaneous balloon mitral valvotomy remains a safe and effective treatment for severe mitral stenosis in experienced centers.
Supports the continued safety of balloon mitral valvotomy in experienced centers; extends real-world.
Background: Rheumatic heart disease (RHD) is still a leading cause of valvular heart disease in India. Balloon mitral valvotomy (BMV) is simple and safe procedure to improve the quality of life in patients with severe mitral stenosis. Aim: (1) To evaluate outcome of RHD patients in tertiary care hospital in developing country like India in twenty first century. (2) To evaluate safety and efficacy of BMV. Materials and Methods: We performed retrospective analysis of 500 patients with RHD undergoing echocardiography in a tertiary care hospital in Maharashtra, India. 15% (74 patients) of them underwent balloon mitral valvuloplasty between June 2012 and November 2019 and 37.6% (188 patients) were treated with valve replacements. Results: Successful BMV was performed in 72 patients. The rate of complication was 2.7%. No mortality was noted. One hundred and eighty-eight patients underwent Valve replacements. Conclusions: Balloon mitral valvuloplasty is a technically difficult procedure and demands considerable expertise in transseptal catheterization. Percutaneous balloon mitral valvotomy is a safe and effective treatment for symptomatic severe Mitral stenosis in experienced centers.
No takes yet. Share an insight, caveat, or question.
Shilpa Deshmukh Kadam (2021) conducted an observational in Rheumatic heart disease (n=500). Balloon mitral valvotomy was evaluated on Complication rate. Balloon mitral valvotomy was successfully performed in 72 of 74 patients with rheumatic heart disease, with a complication rate of 2.7% and no mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: